ArticleNutrition & metabolism2026
The association between life's crucial 9 and osteoarthritis in US adults: the mediating role of central adiposity.
Article in Nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundOsteoarthritis (OA), a prevalent degenerative joint disorder characterized by progressive cartilage loss and secondary low-grade inflammation, is recognized to be associated with cardiovascular diseases (CVD). Building upon the cardiovascular assessment framework of Life’s Essential 8 (LE8), emerging guidelines propose the integration of psychological health metrics (Patient Health Questionnaire-9, PHQ-9) into the expanded Life’s Crucial 9 (LC9) model. While LC9 demonstrates cardiovascular predictive capacity, its role in OA pathogenesis remains inadequately substantiated.
methodsThis study analyzed data from 21,196 National Health and Nutrition Examination Survey (NHANES) participants (2005–2018). Survey-weighted logistic regression, weighted quantile sum (WQS) regression, and restricted cubic splines (RCS) assessed the LC9–OA association with prespecified confounders. Subgroup analyses were also conducted. Mediation analysis was performed to assess the potential mediating effects of central adiposity, specifically the Body Roundness Index (BRI) and Waist-to-Height Ratio (WHtR).
resultsEach 10-point higher LC9 was associated with lower odds of OA (OR = 0.79; 95% CI 0.74–0.84; P < 0.001). Interactions suggested stronger inverse associations in younger adults (≤ 40 years) and in women. WQS regression identified body mass index (33.00%), nicotine exposure (28.40%), and depressive symptoms (13.60%) as the largest contributors to OA risk. While LC9 and LE8 showed comparable discriminatory accuracy (AUC: 0.616 vs. 0.607, P = 0.077), LC9 demonstrated superior reclassification performance (NRI = 0.02, P = 0.002). Mediation analyses indicated that central adiposity accounted for a substantial proportion of the association (WHtR 39.63%; BRI 37.82%). Findings were robust in analyses restricted to adults ≥ 40 years.
conclusionHigher LC9 scores were associated with lower odds of OA, partly mediated by central adiposity. Cardiovascular health metrics that incorporate psychological health may be relevant to OA burden. Prospective studies are needed to establish temporality and causal pathways.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.